KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS for CVS HEALTH
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report | Oct 19, 2021 | $60,000 | Replaced |
| 3rd Quarter - Report (this page) | Oct 20, 2021 | $60,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs and generic drugs. Issues related to continuation of prescription drug access and testing during COVID crisis. Issues related to Medicare Part D rebates.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MAURA KEEFE | Chief of Staff, Senator Shaheen -- 2009-2019, Chief of Staff, Rosa DeLauro 1997-2000; press secretary, Rosa DeLauro 1993-1996 |
Health Issues HCR
Issues involving lowering the cost of healthcare and prescription drug prices; quality health care, patient outcomes, health care delivery. Issues related to affordable health insurance coverage during COVID.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MAURA KEEFE New | Chief of Staff, Senator Shaheen -- 2009-2019, Chief of Staff, Rosa DeLauro 1997-2000; press secretary, Rosa DeLauro 1993-1996 |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.